Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

NCT05254314 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Semaglutide Pen Injector 2.4mg weekly
OTHER: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]